Eli Lilly and Company LLY
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.19% | 16.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.19% | 16.04% | |||
| Cost of Revenue | 20.35% | -8.64% | |||
| Gross Profit | 3.85% | 21.48% | |||
| SG&A Expenses | -8.89% | 16.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.49% | 4.95% | |||
| Operating Income | 5.10% | 27.40% | |||
| Income Before Tax | -9.09% | 4.49% | |||
| Income Tax Expenses | -9.15% | 48.01% | |||
| Earnings from Continuing Operations | -9.08% | -4.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.08% | -4.07% | |||
| EBIT | 5.10% | 27.40% | |||
| EBITDA | 4.97% | 26.29% | |||
| EPS Basic | -9.03% | -3.84% | |||
| Normalized Basic EPS | 1.35% | 31.33% | |||
| EPS Diluted | -9.07% | -3.87% | |||
| Normalized Diluted EPS | 1.32% | 31.34% | |||
| Average Basic Shares Outstanding | -0.06% | -0.23% | |||
| Average Diluted Shares Outstanding | -0.03% | -0.25% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.10% | 0.04% | |||